Articles

June marks a milestone of great importance and excitement for T1D Exchange – it’s been exactly one year since the T1D Exchange Registry launched to the public, bringing together a large number of people with type 1 diabetes from around the country.

Important preliminary findings from the T1D Exchange multi-center surveillance study on people with T1D and COVID-19 were published this week in the Diabetes Care journal.

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

Diversity: The differences in age, race, gender, ethnicity, education, and background within a group – is a critical but often-neglected aspect of research and scientific inquiry. We frequently hear about its importance in many aspects of our life, such as schools and the workplace. However, diversity is particularly important when studying diseases and chronic conditions.

The T1D Exchange Quality Improvement Collaborative (QIC) is a T1D learning health system that includes over 10 endocrinology centers nationwide, working collaboratively on a shared goal of improving outcomes for people with T1D. The program is coordinated by the QI team at T1D Exchange in Boston.

The T1D Exchange outcomes research team worked with Beyond Type 1 and runners in the New York City Marathon to examine the effects and management of type 1 diabetes while engaged in long-distance endurance running.

BOSTON--(BUSINESS WIRE)--T1D Exchange today announced that it will share data from ten abstracts, including six late breaking, focused on quality improvement, population health and real-world evidence and outcomes of people living with type 1 diabetes (T1D) at the American Diabetes Association (ADA) 80th Scientific Virtual Sessions. Two posters from the organization’s Quality Improvement Collaborative were recognized by healthcare information firm Close Concerns in its list of Top 50 Most Notable Posters.

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

Preliminary results of our population health surveillance study, “Type 1 Diabetes and COVID-19: Preliminary Findings from a Multi-Center Surveillance Study in the United States,” were recently published in Diabetes Care, the peer-reviewed medical journal of the American Diabetes Association. The study focuses on individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). This is the first U.S. based, multi-center study to examine patient characteristics and adverse outcomes among individuals with confirmed or suspected COVID-19.

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.